HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

T Miki Selected Research

Pinacidil (Pindac)

12/2003KATP channels depress force by reducing action potential amplitude in mouse EDL and soleus muscle.
9/2001Contribution of both the sarcolemmal K(ATP) and mitochondrial K(ATP) channels to infarct size limitation by K(ATP) channel openers: differences from preconditioning in the role of sarcolemmal K(ATP) channels.
3/2001Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


T Miki Research Topics

Disease

18Neoplasms (Cancer)
11/2005 - 01/2000
10Prostatic Neoplasms (Prostate Cancer)
02/2014 - 06/2000
8Neoplasm Metastasis (Metastasis)
03/2002 - 01/2000
7Ischemia
09/2001 - 07/2000
6Hypertension (High Blood Pressure)
02/2014 - 03/2001
6Lung Neoplasms (Lung Cancer)
12/2006 - 01/2000
5Urinary Bladder Neoplasms (Bladder Cancer)
09/2007 - 01/2001
4Insulin Resistance
02/2014 - 03/2000
4Choroidal Neovascularization
10/2001 - 01/2000
4Infarction
09/2001 - 07/2000
4Carcinoma (Carcinomatosis)
08/2001 - 03/2000
3Carotid Artery Diseases
10/2014 - 01/2001
3Multiple Sclerosis
10/2011 - 05/2008
3Parkinson Disease (Parkinson's Disease)
02/2011 - 12/2010
3Chronic Kidney Failure (Chronic Renal Failure)
08/2006 - 08/2001
3Bone Resorption
11/2003 - 07/2001
3Renal Cell Carcinoma (Grawitz Tumor)
03/2003 - 06/2000
3Body Weight (Weight, Body)
10/2001 - 01/2000
3Graft vs Host Disease (Graft-Versus-Host Disease)
08/2001 - 08/2000
3Myocardial Ischemia (Ischemic Heart Diseases)
07/2001 - 10/2000
3Narcolepsy
03/2001 - 04/2000
3Alzheimer Disease (Alzheimer's Disease)
03/2001 - 06/2000
3Corneal Neovascularization
01/2001 - 01/2000
2Osteoporosis
02/2015 - 01/2001
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2009 - 11/2001
2Testicular Neoplasms (Testicular Cancer)
09/2007 - 04/2000
2Erectile Dysfunction
07/2005 - 08/2002
2Fatigue
12/2003 - 11/2000
2Periodontal Diseases (Periodontal Disease)
11/2003 - 01/2003
2Periodontitis
11/2003 - 07/2001
2Necrosis
03/2002 - 02/2001
2Cicatrix (Scar)
12/2001 - 06/2000
2Contagious Ecthyma (Orf)
12/2001 - 07/2001
2Type 2 Diabetes Mellitus (MODY)
11/2001 - 01/2001
2Vascular System Injuries
10/2001 - 01/2000
2Hypoglycemia (Reactive Hypoglycemia)
05/2001 - 12/2000
2Obesity
05/2001 - 03/2000
2Reperfusion Injury
03/2001 - 12/2000
2Ventricular Remodeling
02/2001 - 07/2000
2Inflammation
02/2001 - 06/2000
2Anemia
12/2000 - 06/2000
2Burns
11/2000 - 01/2000
2Hemorrhage
10/2000 - 01/2000
2Cardiovascular Diseases (Cardiovascular Disease)
09/2000 - 07/2000
1Dementia (Dementias)
02/2014

Drug/Important Bio-Agent (IBA)

7Adenosine Triphosphate (ATP)IBA
09/2006 - 11/2000
6AntigensIBA
10/2011 - 01/2000
4Angiotensin IIIBA
05/2009 - 07/2000
4Complementary DNA (cDNA)IBA
09/2007 - 07/2001
4Fluorouracil (Carac)FDA LinkGeneric
03/2003 - 03/2001
4Cisplatin (Platino)FDA LinkGeneric
03/2003 - 01/2001
41-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2001 - 01/2000
4mitochondrial K(ATP) channelIBA
09/2001 - 07/2000
4Prostate-Specific Antigen (Semenogelase)IBA
01/2001 - 06/2000
3Biological Markers (Surrogate Marker)IBA
02/2010 - 01/2001
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
02/2009 - 07/2000
3Etoposide (VP 16)FDA LinkGeneric
10/2005 - 04/2000
3Pinacidil (Pindac)FDA Link
12/2003 - 03/2001
3Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
03/2003 - 03/2001
3HLA-DRB1 antigen (HLA DRB1)IBA
12/2001 - 02/2001
3Insulin (Novolin)FDA Link
11/2001 - 03/2000
3Retinaldehyde (Retinal)IBA
10/2001 - 05/2000
3Indocyanine Green (Cardio-Green)FDA LinkGeneric
07/2001 - 01/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2001 - 01/2001
3ATX-S10IBA
07/2000 - 01/2000
2Glucose (Dextrose)FDA LinkGeneric
02/2014 - 03/2000
2Brain Natriuretic Peptide (Natrecor)FDA Link
05/2013 - 02/2010
2CalciumIBA
02/2011 - 01/2000
2KATP ChannelsIBA
12/2003 - 05/2001
2Etidronic Acid (HEDP)FDA LinkGeneric
11/2003 - 07/2001
2Fas Ligand Protein (Fas Ligand)IBA
03/2003 - 07/2001
2Messenger RNA (mRNA)IBA
12/2001 - 03/2000
2HLA-DR Antigens (HLA-DR)IBA
12/2001 - 03/2001
2Diazoxide (Hyperstat)FDA Link
09/2001 - 09/2001
2OxidoreductasesIBA
08/2001 - 01/2001
2TaurineFDA Link
07/2001 - 05/2001
2PotassiumIBA
05/2001 - 05/2001
2SodiumIBA
05/2001 - 05/2000
2G(M2) Ganglioside (Ganglioside GM2)IBA
04/2001 - 01/2000
2salicylhydroxamic acid (SHAM)IBA
02/2001 - 07/2000
2valsartan (Vals)FDA Link
02/2001 - 07/2000
2Type 1 Angiotensin ReceptorIBA
02/2001 - 07/2000
2HormonesIBA
01/2001 - 12/2000
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2000 - 10/2000
2Fluorescein (Funduscein)FDA LinkGeneric
01/2000 - 01/2000
1denosumabFDA Link
02/2015
1Alanine-glyoxylate transaminase (alanine-glyoxylate aminotransferase)IBA
10/2014
1FructoseIBA
02/2014
1alpha-caroteneIBA
02/2014
1Carotenoids (Carotene)IBA
02/2014
1beta Carotene (Betacarotene)FDA Link
02/2014

Therapy/Procedure

7Drug Therapy (Chemotherapy)
11/2005 - 04/2000
5Renal Dialysis (Hemodialysis)
12/2006 - 08/2001
5Photochemotherapy (Photodynamic Therapy)
10/2001 - 01/2000
4Heterologous Transplantation (Xenotransplantation)
03/2003 - 08/2000
4Lasers (Laser)
10/2001 - 01/2000
4Semiconductor Lasers
10/2001 - 01/2000
4Intravenous Injections
10/2001 - 01/2000
2Prostatectomy (Retropubic Prostatectomy)
10/2001 - 07/2001
2Light Coagulation
11/2000 - 01/2000